Enterprise Value
177.8M
Cash
140.2M
Avg Qtr Burn
-15.56M
Short % of Float
4.29%
Insider Ownership
0.91%
Institutional Own.
84.80%
Qtr Updated
06/30/23
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
INZ-701 (ENPP1-Fc) Paediatric Details ENPP1 deficiency, Genetic disorder, Rare genetic disease | Phase 3 Initiation | |
INZ-701 Details Genetic disorder, ABCC6 Deficiency, Rare genetic disease | Phase 2 Data readout | |
INZ-701 (ENPP1-Fc) Details ENPP1 deficiency, Genetic disorder, Rare genetic disease | Phase 2 Data readout | |
INZ-701 (ENPP1-Fc) Details ENPP1 deficiency, Genetic disorder, Rare genetic disease | Phase 1 Interim update |